塞栓剤市場 - 2031年の成長予測、統計および事実

  • Report Code : TIPRE00025058
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 219
Buy Now

塞栓剤市場は、2021 年の 27 億 1,482 万米ドルから、2028 年までに 45 億 2,575 万米ドルに達すると予測されています。 2021 年から 2028 年にかけて 7.6% の CAGR で成長すると予想されています。

市場の成長は、腫瘍や動脈瘤の発生率の増加、高血圧、肥満、喫煙、アルコール依存症の有病率の増加に起因すると考えられます。しかし、塞栓剤のコストが高いため、塞栓剤市場の成長が抑制されています。塞栓剤は、機械的閉塞を適用して血管または血管領域内の血流を止めるために使用されます。インターベンショナル放射線学では、塞栓術は一般的な処置です。塞栓術は主に外傷の治療に使用されます。塞栓剤にはさまざまな形態があり、それぞれに独自の特性と用途があります。動脈閉塞に必要な期間に応じて、塞栓剤は一時的または永続的なものに分類されます。

戦略的洞察
米国では、いぼ治療処置の需要が減少しています。新型コロナウイルス感染症の治療に焦点を当てる。新型コロナウイルス感染症(COVID-19)のパンデミックは、世界のサプライチェーン、消費者市場、経済に大混乱を引き起こしています。この状況により、アジア太平洋地域のさまざまな国で行われる心臓手術が減少しています。世界中の政府が実施した措置は、塞栓剤市場の成長に悪影響を及ぼしています。

塞栓剤市場にとって有利な地域



市場洞察
腫瘍と動脈瘤の発生率の増加が塞栓剤市場の成長を促進
国立がん研究所によると、2020年には新たながん症例数が1,806,590人、がんによる死亡者数が606,520人でした。アメリカの病気。 2020年には、前立腺がん、肺がん、および結腸直腸がんが、男性で診断されたがん全体の43%を占めました。乳がん、肺がん、および結腸直腸がんは、女性で最も頻繁に診断される 3 つのがんです。脳動脈瘤財団の統計と事実の報告書によると、米国では約 650 万人、つまり 50 人に 1 人が未破裂脳動脈瘤を患っています。また、脳動脈瘤と診断された人の全体の 20% が複数の動脈瘤を抱えていることにも言及しています。さらに、米国では毎年約 30,000 人が脳動脈瘤破裂に苦しんでおり、脳動脈瘤破裂は 18 分ごとに発生していると報告しています。さらに、NHS によると、イギリスでは毎年 12,500 人に 1 人が脳動脈瘤破裂を起こしています。さらに、「未破裂頭蓋内動脈瘤の病因と個別管理」に従って、 2020年にDeutsches Ärzteblatt Internationalに掲載された報告書によると、ドイツでは約200万人(成人)が未破裂頭蓋内動脈瘤(IA)を患っています。塞栓剤は、機械的閉塞によって血管または血管領域の流れを急激に止めるために使用されます。塞栓微小球(ビーズ)などの塞栓剤は、腫瘍への血管供給を制限するために使用され、組織内に溶出および拡散する化学療法薬を充填することができます。液体塞栓剤は、動脈瘤や腫瘍への血液供給を防ぐために使用されます。したがって、動脈瘤やがんの蔓延により、塞栓剤に対する高い需要が生じています。

製品ベースの洞察

塞栓剤市場は、製品に基づいて、コイル、ビーズ/粒子、プラグ、取り外し可能なバルーン、接着剤、スポンジ、液体塞栓剤、硬化剤、沈殿剤など。ビーズ/粒子セグメントは市場で最大のシェアを占めています。ただし、コイルセグメントは 2021 年から 2028 年にかけて最高の CAGR を記録すると予想されます。コイル塞栓術は、血管内の異常な血流を正確に閉塞できるカテーテルベースの処置です。心臓手術の件数の増加が、このセグメントの市場成長を推進しています。

塞栓剤市場、製品別 – 2021 年と 2028 年



アプリケーション - ベースの洞察

アプリケーションに基づいて、塞栓剤市場は神経学、腫瘍学、心臓学、末梢血管疾患など。腫瘍学分野は市場で最大のシェアを占めており、予測期間中に市場で最高の CAGR を記録すると予想されています。

エンドユーザーベースの洞察

エンドユーザー、塞栓剤に基づいた分析市場は病院、外来手術センター、心臓センターなどに分割されています。病院セグメントは最大の市場シェアを保持しており、予測期間中に最高の CAGR を記録すると推定されています。このセグメントの市場の成長は、世界中で病院の数が増加し、外科手術の数が急速に増加していることに起因しています。

塞栓剤市場で事業を展開している企業は、進化する市場に対応するための製品イノベーション戦略を採用しています。世界中の顧客の需要に対応できるため、世界市場でブランド名を維持することもできます。

塞栓剤市場 –製品別

  • コイル
    • 取り外し可能コイル
    • プッシュ可能コイル
  • ビーズ/粒子
    • 球形
    • 非球形
  • プラグ
  • 取り外し可能なバルーン
  • 接着剤
  • li>
  • スポンジ
  • 液体塞栓剤
  • 硬化剤
  • 沈殿剤
  • その他

塞栓剤市場–アプリケーション別

  • 腫瘍学
  • 神経学
  • 泌尿器科
  • 心臓病学
  • 末梢血管疾患
  • >
  • その他

塞栓剤市場 –エンドユーザー別

  • 病院
  • 心臓センター
  • 外来外科センター
  • その他
< h3>塞栓剤市場–地理別
  • 北アメリカ
    • 米国
    • カナダ
    • メキシコ
  • < li>ヨーロッパ
    • フランス
    • ドイツ
    • イタリア
    • イギリス
    • スペイン
    • 残りヨーロッパ
  • アジア太平洋 (APAC)
    • 中国
    • インド
    • 韓国
    • 日本
    • オーストラリア
    • アジア太平洋地域のその他の地域
  • 中東およびアフリカ (MEA)
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • MEAの残りの部分
  • 中南米(SCAM) )
    • ブラジル
    • アルゼンチン
    • その他の SCAM

会社概要

  • メドトロニック
  • テルモ株式会社
  • クック メディカル LLC
  • ボストン サイエンティフィック コーポレーション
  • アボット
  • < li>Stryker Corporation
  • Penumbra, Inc.
  • Merit Medical Systems Inc.
  • DePuy Synthes
  • カネカ株式会社
  • < /ul>
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are embolization agents?

Embolization agents are used to apply mechanical occlusion to stop the flow of blood in a blood vessel or vascular area. In interventional radiology, embolization is a common procedure. Embolization procedures are most used to treat traumatic injuries. Embolic agents come in a variety of forms, each with its own set of properties and applications. Depending on the duration of time that arterial occlusion is required, embolization agents are classified as temporary or permanent.

What are the driving factors for the embolization agents market across the globe?

The factors that are driving growth of the market are rising incidence of tumors and aneurysms, and growing incidence of hypertension, obesity, smoking, and alcoholism.

Who are the developments carrying out by major players in the embolization agents market?

Various companies have made organic growth strategies in the embolization agents market. Some of the activities undertaken by the company, which have promoted its growth are, launches, enhancements and expansion & relocation activities. Companies such as Medtronic, Cook Medical LLC amongst others are some of the companies that have been implementing various organic strategies that have helped the growth of the company.

Which region is dominated the embolization agents market?

North America dominates the global embolization agents market due to factors such as increasing incidences of the neurological disorders such as stroke, brain aneurysms and others across the country, increasing product launches, well-developed healthcare facility centres equipped with modern-age equipment and instruments.

Which segment is growing at the highest CAGR in the embolization agents market?

The coil segment is growing at the highest CAGR owing to increasing number of cardiac surgeries.

Which region is the fastest growing in the embolization agents market?

Asia Pacific is expected to be the fastest growing region in the embolization agents market. The growth of the market in this region is primarily due to factors such as rising prevalence of the brain stroke, coronary artery diseases, heart diseases, increasing surgical procedures, growing number of hospitals and ambulatory surgeries centers, focus by industry players in Japan and developing healthcare infrastructure in India are likely to boost the market growth in forecast period.

The List of Companies - Embolization Agents Market

  1. Medtronic
  2. Terumo Corporation
  3. Cook Medical LLC
  4. Boston Scientific Corporation
  5. Abbott
  6. Stryker Corporation
  7. Penumbra, Inc.
  8. Merit Medical Systems Inc.
  9. DePuy Synthes
  10. KANEKA CORPORATION            

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports